Fore Biotherapeutics Company

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Technology:
Small Molecules
Industry:
Geroscience
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2011-01-01
Employees Number:
11-50
Investors Number:
12
Total Funding:
91500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-09-15
Last Funding Type:
Series C
Register and Claim Ownership